Sex-related disparities in migraine recognition and management: insights from a tertiary headache center cohort
Abstract
Migraine is a highly prevalent and disabling neurological disorder that is often underdiagnosed and undertreated, particularly in early stages of care. Sex-related factors may contribute to this gap. This study investigates sex-related disparities in migraine recognition and management before and after presentation at a tertiary headache center and examines whether these disparities are linked to differences in clinical presentation. In this retrospective cross-sectional study, we included patients diagnosed with migraine between December 2015 and January 2023 at the Headache Center of Charité – Universitätsmedizin Berlin. We analyzed sex-related differences in prior diagnosis, clinical presentation, migraine burden, and treatment strategies both before referral and following tertiary care evaluation. Among 1,130 patients with migraine (82% women, 18% men), men were significantly less likely than women to have received a migraine diagnosis prior to tertiary center evaluation (57.0% vs. 73.8%; OR = 0.47, p < 0.001). Clinical presentation also differed between sexes: men reported lower pain intensity and shorter attack duration, whereas women more frequently experienced unilateral headache, nausea, vomiting, photophobia, and osmophobia. In women, canonical migraine features (unilateral headache, pulsating pain, aggravation by physical activity, and migraine-associated symptoms) were each associated with lower odds of missed diagnosis before referral. By contrast, in men,…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 1,130 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.